Filter By Industry
Filter By Tag

Newsroom

Markus Spielmann Press releases

1 - 5 of 5 Press Releases

Feb 15, 2017
Markus Spielmann Inc. analyst Ralph Morrison offers a bullish take on Netflix, Inc. after adding the online streaming giant's addition to the 246th Current Better Values List.

Feb 15, 2017
Markus Spielmann Inc.'s Eleanor Prior noted that GWPharmaceuticals will have three ongoing Phase III programs by the end of the year for its lead candidate, a transdermal synthetic cannabidiol (CBD), with results expected in the first half of 2017, which.

Feb 02, 2017
Today, Markus Spielmann Inc. reiterated its Buy rating on Starbucks Corporation with a price target of $70.00.

Jan 26, 2017
PHILANTHROPY What does it mean to you? Philanthropy means lots of different things to different people and the varied ambitions of our clients are a reflection of their diverse range of backgrounds.

Jan 25, 2017
Analysts at Markus Spielmann Inc. suggested that Kite Pharma's experimental cancer therapy KTE-C19 has blockbuster potential, as reported in the Tuesday.


Markus Spielmann RSS Feed